James H. Sabry, CEO at CYTOKINETICS INC (CYTK), sold 7,000 shares at $7.51 ($51K) on 2006-12-01, disclosed to the SEC on 2006-12-04.
Scheduled sale ($51k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.18 | 37 | $266 | 0.5% |
| 2 | $7.19 | 363 | $3K | 5.1% |
| 3 | $7.20 | 200 | $1K | 2.8% |
| 4 | $7.22 | 200 | $1K | 2.8% |
| 5 | $7.23 | 100 | $723 | 1.4% |
| 6 | $7.25 | 200 |
| $1K |
| 2.8% |
| 7 | $7.26 | 200 | $1K | 2.8% |
| 8 | $7.28 | 800 | $6K | 11.3% |
| 9 | $7.29 | 669 | $5K | 9.5% |
| 10 | $7.30 | 231 | $2K | 3.3% |
| 11 | $7.31 | 272 | $2K | 3.9% |
| 12 | $7.32 | 200 | $1K | 2.9% |
| 13 | $7.33 | 376 | $3K | 5.4% |
| 14 | $7.34 | 100 | $734 | 1.4% |
| 15 | $7.35 | 152 | $1K | 2.2% |
| 16 | $7.36 | 338 | $2K | 4.8% |
| 17 | $7.37 | 362 | $3K | 5.2% |
| 18 | $7.38 | 300 | $2K | 4.3% |
| 19 | $7.40 | 700 | $5K | 10.1% |
| 20 | $7.41 | 400 | $3K | 5.8% |
| 21 | $7.42 | 100 | $742 | 1.4% |
| 22 | $7.47 | 200 | $1K | 2.9% |
| 23 | $7.48 | 200 | $1K | 2.9% |
| 24 | $7.49 | 100 | $749 | 1.5% |
| 25 | $7.51 | 102 | $766 | 1.5% |
| 26 | $7.52 | 98 | $737 | 1.4% |
| Total | $7.33 avg | 7,000 | $51K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |